AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| HLG D&O Ongoing Disclosure - Stuart Duncan | |||
| 20/04/18 | |||
| HLG D&O Ongoing Disclosures - Multiple | |||
| 05/04/18 | |||
| HLG Appendix 7 | |||
| 03/04/18 | |||
| HLG Results for the 6 Month Period Ended 1 February 2018 | |||
| 29/03/18 | PRICE SENSITIVE | ||
| HLG Sale of Storm Business Assets | |||
| 16/03/18 | PRICE SENSITIVE | ||
| HLG Directors & Officers Ongoing Disclosure | |||
| 09/03/18 | |||
